- Solutions Overview
- Clinical Development
- Outsourcing Services
- Parexel® Biotech
- Medical Affairs
- Real-World Evidence and Late Phase
- Our Company
- Management Team
- Diversity, Equity and Inclusion
- Career Opportunities
- Trust & Privacy
Taking a molecule from discovery to new treatment is a valuable journey. But it’s a journey laden with complexities and obstacles. We know that the success of your objective depends on deep knowledge, planning, and commitment. It’s why we’ll map out the entire route with you, step by step, so you can start the process with confidence, not apprehension. It’s why our team of passionate and dedicated professionals are unyielding in their approach, treating the first and final phases with equal vigor. And above all, it’s why we exist – to stand with you as you develop your new medicine and continue to develop modern medicine itself.
By engaging early with key stakeholders – regulators, payers, physicians and patients – our Regulatory & Access consultants are forewarned of potential stumbling blocks, and build productive, constructive relationships that support your development program. That means all the way from before IND submission, to local market approval, through market access, and throughout the product lifecycle. Helping you demonstrate a clear proposition of your products potential, supported with evidence of safety, efficacy and value.
We are always available for a conversation.